跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAAXIA EYEDROPS 4.9 g/100 ml - HSA Drug Approval Details
Approvals
/
HSA
/
NAAXIA EYEDROPS 4.9 g/100 ml
Approved
THERAPEUTIC
NAAXIA EYEDROPS 4.9 g/100 ml
LABORATOIRES THISSEN SAExcelvision
🇸🇬 Health Sciences Authority
Approval Date
Nov 11, 1999
Approval ID
f804d1b2989040a0
Company
LABORATOIRES THISSEN SAExcelvision
Type
Therapeutic
Approval Details
Approval Id
f804d1b2989040a0
Drug Name
NAAXIA EYEDROPS 4.9 g/100 ml
Product Name
NAAXIA EYEDROPS 4.9 g/100 ml
Approval Number
SIN11221P
Approval Date
1999-11-11
Registrant
DCH AURIGA SINGAPORE
Licence Holder
DCH AURIGA SINGAPORE
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
SOLUTION
Dosage
**DOSAGE:** One drop, 2 to 6 times daily.
Route Of Administration
OPHTHALMIC
Indication Info
**INDICATIONS:** Conjunctivitis and blepharoconjunctivitis of allergic origin.
Contraindications
**CONTRA-INDICATIONS:** IN DOUBT, SEEK ADVICE FROM YOUR DOCTOR OR PHARMACIST.
Atc Code
S01GX03
Atc Item Name
spaglumic acid
Pharma Manufacturer Name
DCH AURIGA SINGAPORE
Company Detail Path
/organization/dch-auriga-singapore
Active Ingredients
N-ACETYL ASPARTYL GLUTAMIC ACID SODIUM SALT
4.9 g/100 ml
N-ACETYL ASPARTYL GLUTAMIC ACID SODIUM SALT
4.9 g/100 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 11, 1999
Approval ID
f804d1b2989040a0
Type
Therapeutic
Back to HSA Approvals